According to Effectiveness and Cost
The list of VED-2017 is being revised.
The work of commission on revision of the list according to clinical efficacy and cost assessment is ongoing on-line. Anyone can follow-up its activities on-line and even take part in its work.
It should be noted, that according to the law , the list of vital and essential drugs is updated on the annual basis. In 2015 the list included 608 international non-proprietary names (INN), in 2016 the list has grown to 646 items. It is yet too early to predict how the list will look like in 2017. Veronika Skvortsova, Russian Minister of Healthcare, stressed, that the best experts are working on the list. It is a step-by-step process. In particular, clinical efficacy and cost effectiveness is evaluated.